THIS EVENT IS NOT OPEN TO THE PUBLIC.
This CME is jointly provided by the Medical Society of Delaware and the Delaware Society for Oncology.
Presented by: Tara Gangadhar, MD, Assistant Professor of Medicine, Hematology-Oncology Division, Abramson Cancer Center, University of Pennsylvania
Objectives:
At the conclusion of this activity, participants will be able to:
· Recognize active immune therapies recently approved for the treatment of advanced cancer;
· Name immune therapies currently being tested in patients with advanced cancer;
· Discuss combination therapy approaches being investigated in clinical trials as strategies to overcome resistance to therapy.